The H&E staining verified that DDC or MCD successfully induced cholestasis or NASH in mice, and the level of fibrosis and HSC activation was significantly lower in Runx2‐deficient mice compared to the controls (Figure 3E). This evidence concerns the gene RUNX2 and metabolic dysfunction-associated steatohepatitis.